L’accident vasculaire cérébral (AVC) est l’une des principales causes de mortalité dans le monde. Sile taux de de mortalité associé à l’AVC a sensiblement diminué dans les dernières décennies, cela estprincipalement du à l’amélioration globale de l’état de santé de la population et non à la découverte d’untraitement thérapeutique contre l’AVC et de nombreux survivants garderont des séquelles. Dans ce contexte,l’influence de la nutrition qui pourrait jouer un rôle central dans la résistance à l’AVC reste très peu étudier.Pourtant de nombreuses études épidémiologiques confèrent des propriétés protectrices à certaines moléculesnaturelles comme les acides gras polyinsaturés oméga-3.Dans un modèle murin d’AVC, notre laboratoire ayant montré que la consommation d’un régimeenrichi en acide a-linolénique (ALA), l’oméga-3 végétal, réduisait le volume d’infarctus cérébral, mestravaux ont porté sur l’effet de la supplémentation nutritionnelle en ALA. J’ai montré que la supplémentationen ALA par voie orale ou intraveineuse favorise la récupération cognitive post-AVC. Ces bénéfices sontassociés à la préservation des neurones de l’hippocampe, une structure cérébrale impliquée dans la mémoire.Par la suite, je me suis intéressé à l’effet de l’ALA sur la réponse inflammatoire pos-AVC, une composantemajeure dans l’étendue des séquelles. J’ai pu ainsi caractériser le rôle neurotoxique de la chimiokine CCL2 etd’identifier la réduction de son expression post-AVC, comme un facteur clé de la protection cérébrale induitepar la supplémentation en ALA. De plus, une étude collaborative nous a permis de mettre en évidencel’implication de la voie de signalisation de cette chimiokine dans la perte de poids induite par uneinflammation du système nerveux central. Mes travaux soulignent l’importance de la supplémentation en ALA pour réduire les conséquences d’un AVC, en ciblant la réponse pro-inflammatoire post-ischémique, apportant une preuve supplémentaire del’intérêt de l’ALA contre l’une des priorités les plus urgentes de la médecine / Stroke is a worldwide major cause of mortality and morbidity without any therapeutic opportunities.While improvements in population health - in the control of major risk factors of stroke - over the pastdecades have contributed to reduced stroke mortality, numerous therapeutics applied acutely after stroke havefailed to improve long-term clinical outcomes. Weirdly, how nutrition may affect stroke damage and recoveryhas not yet been intensely investigated, which is surprising given its great influence as risk factor. Therefore,our lab is investigating an emerging view that is the health potential of a-linolenic acid (ALA is the omega-3contained in plant-derived edible products) in stroke.Our laboratory has previously shown that ALA injections or dietary supplementation reduces strokedamage by direct neuroprotection in rodent models of stroke. As successful translation of putative therapieswill depend on demonstration of efficacy on stroke-induced motor and cognitive deficits, my PhD work hasevaluated the value of ALA supplementation in stroke recovery. I demonstrated that oral and intravenoussupplementation of ALA improved cognitive recovery, which was associated to a better preservation ofhippocampus, a brain structure involved in memory. Looking for mechanistic insights, I also investigated theeffect of ALA supplementation by modification of the daily diet on post-stroke inflammatory response. Wefirst demonstrated a neurotoxic role of the chemokine CCL2 after stroke and identified its reduction, as a keyfactor in brain protection induced by ALA supplementation. In addition, I also contributed to a collaborativestudy deciphering the role of CCL2 in weight loss induced by inflammation of the central nervous system.To conclude, my PhD highlights the importance of ALA supplementation to reduce the consequencesof stroke, targeting post-ischemic pro-inflammatory response and prepare the ground of clinical trial onnutritional interventions that are yet to be evaluated

Sperm function has been studied in multiple research fields as it is essential to male fertility. In previous studies a variety of sperm traits have been examined as an assessment of sperm function. Among those traits, sperm viability, sperm motility and sperm metabolism are often commonly examined. However, sperm function can be influenced by both environmental and genetic factors. Specifically, nuclear genome has been demonstrated to play a role in sperm function, especially in sperm competitive capacity. There are increasing evidence for effects of mitochondrial genome on sperm function. Mitochondrial genetic variance has been suggested to affect sperm length and sperm viability in seed beetle and sperm metabolism in rodent. Given the coordinated collaborations between nuclear and mitochondrial genomes in OXPHOS, replication and transcription of mitochondrial genome as well as intergenomic signalling, potential mitonuclear effects on sperm function are expected even though empirical evidence so far remains less. A recent review summarised all the previous work on environmental effects on sperm and found that various factors affects sperm function but largely neglected in ecology and evolution. In the study, we used D. melanogaster as a model to disentangle both genetic and environmental components of sperm function at sperm cell, ejaculate and offspring levels. We found environmental effects on sperm function in D. melanogaster. Specifically, sperm incubation buffers affect sperm viability in chapter 2 and dietary PUFAs influence sperm volume and metabolism in chapter 4. Nuclear effects were found on sperm viability, sperm quality and male fertility in chapter 3. Mitochondrial genome was found to have an effect on sperm function, i.e. sperm viability and sperm quality differed among mitochondrial haplotypes examined. In addition, sperm function was further modified by the interaction of nuclear and mitochondrial genomes in ageing male. Sperm quality and fertilization success were suggested to be dependent on age-related mitonuclear interaction in chapter 3. Moreover, we examined the mitonuclear coadaptation hypothesis in the function of D. melanogaster sperm. No evidence for mitonuclear coadaptation hypothesis was found for sperm function in D. melanogaster as there were no difference between coadapted and non-coadapted lines in sperm traits examined. Lastly, we found that sperm viability, sperm quality and sperm metabolic rate cannot predict male fertility in D. melanogaster as correlation analysis revealed no relationship between them. Our experiment explored and disentangled the genetic and environmental components of sperm function at multiple levels in D.melanogaster systematically. Our results suggested that both mitochondrial and nuclear genome as well as the interaction between them play a role in sperm function in D. melanogaster. In addition to genetic components, our findings revealed environmental components of Drosophila sperm and suggested that it was phenotypic plastic.

<p>PUFAs serve many important biological and physiological functions within the body and are key for the structure and function of the brain. Omega-6 and omega-3 PUFAs are found in abundance in phospholipids of neuronal membranes that impart structure and function of neurons. Omega-6 PUFAs are instrumental for neurotransmission, neuronal elongation, and neuritogenesis; whereas, omega-3 PUFAs promote neuronal maturation through synaptogenesis. The types of PUFAs incorporated into neuronal membranes is especially important in determining the progression of development. The processes of neurogenesis, neuritogenesis and elongation require large amounts of PUFAs to be incorporated into the membrane phospholipids. To accommodate for the high PUFA needs, maternal dietary PUFA, especially EPA and DHA, recommendations, mobilization of fatty acids into maternal circulation increases, and the accretion rate of PUFA are increased. If maternal nutritional inadequacy of PUFAs occurs during gestation, this can result in impaired cognition, behavioral abnormalities, reduced number of neurons, decreased dendric arborization, altered myelin sheath, and a reduction in brain size. </p> <p> Even though the essentiality of PUFAs in neuronal development is widely accepted, the mechanism is not well understood. There is a lack of consensus in the current literature on the effects of individual PUFAs on each stage of neuronal development and the molecular pathways involved. Despite the inconsistent evidence, the results of numerous studies have consistently suggested that neuronal membrane PUFA composition is associated with neuronal development outcomes, such as number of neurons and neurites, neurite length, and neurotransmitter release. The varying results may be the result of methodological discrepancies with PUFA composition and concentrations, as well as the models used for neuronal development. Additionally, very few studies have taken into consideration the competitive relationship of omega-6 and omega-3 PUFAs in the body when assessing neurodevelopment. </p> <p> This thesis was focused on addressing the role of PUFAs in neuronal development and to address some of the inconsistencies in the literature. attempt to elucidate the individual roles of ALA, ARA, and EPA on neuronal membrane composition and neuronal development. The aim of the thesis research project was to assess the impact of individual PUFAs on neuronal membrane PUFA composition, the membrane n-6:n-3 ratio, and the morphology of SH-SY5Y cells during differentiation. The results of this study demonstrated that supplementation of individual PUFAs alters membrane PUFA composition and the n-6:n-3 ratio. However, there wasn’t a significant effect on neurite number with ALA, ARA, and EPA treatment. Lastly, ARA treatment decreased cell viability compared to the other treatments and the BSA control. Furthermore, additional research needs to be conducted to address other morphological measures and functional outcomes, such as neurotransmitter production and release.</p>

No description available.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Fatty acids (FA) are constituents of neuronal phospholipid membranes, where they are essential for the development and functioning of the brain. During the peak of neuronal growth, occurring during the last week of gestation and lactation, there is a rapid accumulation of long-chain polyunsaturated FA (LC-PUFAs), which are synthesized from a physiologically appropriate supply of essential fatty acids (EFA) for normal fetal and neonatal development , ensuring the development of neurological functions. During the last decades, there occurred changes in dietary habits in Western countries, mainly with increased consumption of trans fatty acids (TFA) and omega-6 (n-6) at the expense of consumption of omega-3 (n-3). These changes may increase oxidative damage and alter neuronal neuroplasticity, thereby facilitating the development of neuropsychiatric diseases such as bipolar disorder (BD). Through a model of amphetamine-induced mania in rats, we evaluated comparatively the influence of daily supplementation of different fats since pre-conception until weaning of 1st and 2nd generation litters on behavioral parameters in conjunction with biochemical changes in brain regions. Three groups of female Wistar rats were supplemented (3g/kg; p.o. per day) from one week before conception through pregnancy and breast-feeding with fish oil (FO, rich in n-3 PUFA), soybean oil (SO; rich in PUFA n-6) or hydrogenated vegetable fat (HVF; rich in TFA). During weaning, pups of both sexes were kept under the original supplementation until 90 days of age. While male offspring were included in the study of the 1st generation, females were mated and maintained in the same supplementation, thus obtaining animals of the 2nd generation, which were used in the 2nd study and divided into 3 experiments. In the study of the 1st generation at 90 days of age, one half of each supplementation group was treated with a daily dose of amphetamine (AMPH 4mg/kg, ip) or saline (control) for 14 days, when they were subjected to behavioral tests and biochemical assessments in the cortex, striatum and hippocampus. HVF supplementation was associated with TFA incorporation in the three structures, increased AMPH-induced locomotor activity, and increased oxidative damage. Since FO supplementation increased DHA percentage and decreased the n6/n3 ratio in the three regions analyzed, it may have improved membrane fluidity and reduced oxidative stress in such animals. Adult male rats born from the 2nd generation were also exposed to an animal model of mania induced by amphetamine and used in two different experiments. In the first experiment, animals were evaluated for memory behavior and biochemical and molecular analysis in the hippocampus, in which these parameters were decreased by HVF supplementation and improved by FO supplementation. In the second experiment, animals were evaluated regarding hyperactivity and biochemical and molecular analyses in the cortex, where again HVF supplementation was associated with loss in some parameters. In a third experiment we evaluated the influence of trans fat supplementation in rats exposed to the same mania animal model and the response to lithium (a mood stabilizing drug) treatment in 1st and 2nd generation animals. Lithium was able to reverse all AMPH-induced effects. Taken together, our findings suggest that the increased consumption of processed foods, which are rich in trans fat, may be related to an increased incidence of neuropsychiatric conditions. Conversely, a balanced diet, which includes omega-3 sources , reduces susceptibility to developing such conditions, possibly by changing the composition of the neuronal phospholipid membrane. / Ácidos graxos (AG) são fosfolipídeos constituintes das membranas neuronais onde são fundamentais para o desenvolvimento e funcionamento do cérebro. Durante o pico do crescimento neuronal, o qual ocorre durante a última semana de gestação e período de aleitamento, há um rápido acúmulo de AG poliinsaturados de cadeia longa (AGPI-CL) para o desenvolvimento fetal e neonatal normal, garantindo o desenvolvimento de suas funções neurológicas. Durante as últimas décadas foram observadas mudanças nos hábitos alimentares, principalmente em países ocidentais, devido ao aumento do consumo de AG trans e ômega-6 (n-6) em detrimento do consumo de AG ômega-3 (n-3). Estas mudanças podem favorecer o desenvolvimento de processos oxidativos e alterar a neuroplasticidade neuronal, facilitando assim o desenvolvimento de doenças neuropsiquiátricas, e dentre estas, o transtorno bipolar (TB). Através de um modelo animal de mania induzido por anfetamina, avaliamos comparativamente a influência da suplementação diária de óleos ou gordura desde o período pré-concepcional até o desmame das ninhadas em regiões cerebrais dos filhotes de 1ª e de 2ª geração. Três grupos de ratas Wistar foram suplementadas diariamente (3g/kg/v.o.) desde uma semana antes da concepção, durante a gestação e aleitamento com óleo de peixe (OP, rico em AGPI n-3); óleo de soja (rico em AGPI n-6) ou gordura vegetal hidrogenada (GVH; rica em AGT). No período de desmame, filhotes de ambos os sexos foram mantidos sob a mesma suplementação original até 90 dias de idade. Enquanto os filhotes machos foram incluídos no estudo da 1ª geração, as fêmeas foram separadas e acasaladas nas mesmas condições de suplementação já descritas, obtendo-se assim, animais adultos de 2ª geração, os quais foram incluídos no 2º estudo e divididos em 3 experimentos. No estudo de 1ª geração, aos 90 dias de idade, metade de cada suplementação foi tratada com uma dose diária de anfetamina (4mg/Kg, ip) ou solução salina (controle), durante 14 dias, quando foram submetidos aos testes comportamentais e avaliações bioquímicas no córtex, estriado e hipocampo. A suplementação com GVH favoreceu a incorporação de AGT nas três estruturas cerebrais descritas, aumentou a atividade locomotora induzida por ANF e aumentou os danos oxidativos. Já a suplementação com OP permitiu um aumento da porcentagem de DHA, diminuindo a razão AGPI n6/n3 nas três regiões avaliadas, o que pode ter contribuído para uma maior fluidez das membranas neurais e menor incidência de danos oxidativos. Ratos machos adultos da 2ª geração foram também expostos ao modelo animal de mania induzido por anfetamina, sendo porém separados em dois experimentos distintos: no primeiro experimento, além de avaliações comportamentais relacionadas à memória, marcadores do status oxidativo e análises moleculares foram feitas no hipocampo, sendo observado um prejuízo destes parâmetros no grupo suplementado com GVH, enquanto o grupo OP mostrou efeitos benéficos. No segundo experimento, além do comportamento locomotor, análises bioquímicas e moleculares foram feitas no córtex, quando novamente, a suplementação com GVH mostrou efeitos deletérios. No terceiro experimento avaliamos a influência da suplementação de gordura trans em animais de 1ª e 2ª geração sobre o mesmo modelo animal de mania e a resposta farmacológica ao carbonato de lítio (droga estabilizadora do humor), quando observamos que o lítio foi capaz de reverter todos efeitos induzidos pela ANF. Tomados em conjunto, os dados apresentados nesta tese sugerem que o consumo aumentado de alimentos industrializados, os quais são ricos em grodura trans, podem estar envolvidos no aumento da incidência de doenças neuropsiquiátricas. Contrariamente, uma alimentação balanceada, a qual inclui fontes de omega-3, reduz a suscetibilidade para o desenvolvimento de tais condições, em decorrência das possíveis alterações na composição fosfolipídica das membranas neurais.

Yes / Abstract Objective Omega-3 polyunsaturated fatty acids (PUFAs) have anticolorectal cancer (CRC) activity. The intestinal microbiota has been implicated in colorectal carcinogenesis. Dietary omega-3 PUFAs alter the mouse intestinal microbiome compatible with antineoplastic activity. Therefore, we investigated the effect of omega-3 PUFA supplements on the faecal microbiome in middle-aged, healthy volunteers (n=22). Design A randomised, open-label, cross-over trial of 8 weeks’ treatment with 4 g mixed eicosapentaenoic acid/docosahexaenoic acid in two formulations (soft-gel capsules and Smartfish drinks), separated by a 12-week ‘washout’ period. Faecal samples were collected at five time-points for microbiome analysis by 16S ribosomal RNA PCR and Illumina MiSeq sequencing. Red blood cell (RBC) fatty acid analysis was performed by liquid chromatography tandem mass spectrometry. Results Both omega-3 PUFA formulations induced similar changes in RBC fatty acid content, except that drinks were associated with a larger, and more prolonged, decrease in omega-6 PUFA arachidonic acid than the capsule intervention (p=0.02). There were no significant changes in α or β diversity, or phyla composition, associated with omega-3 PUFA supplementation. However, a reversible increased abundance of several genera, including Bifidobacterium, Roseburia and Lactobacillus was observed with one or both omega-3 PUFA interventions. Microbiome changes did not correlate with RBC omega-3 PUFA incorporation or development of omega-3 PUFA-induced diarrhoea. There were no treatment order effects. Conclusion Omega-3 PUFA supplementation induces a reversible increase in several short-chain fatty acid-producing bacteria, independently of the method of administration. There is no simple relationship between the intestinal microbiome and systemic omega-3 PUFA exposure. / NIHR/EME Yorkshire Cancer Research (YCR)

Mehrfach ungesättigte omega-3 Fettsäuren (n-3 PUFAs), wie Eicosapentaensäure (EPA) und Docosahexaensäure (DHA), schützen vor kardiovaskulären Erkrankungen, wie tödlichen Arrhythmien. In vitro Untersuchungen belegen, dass rekombinante Cytochrom P450 (CYP) Enzyme nicht nur die n-6 PUFA Arachidonsäure (AA), sondern auch die n-3 PUFAs EPA und DHA als alternative Substrate verwenden. Dabei entstehen bioaktive regio- und stereoisomere Epoxy- und Hydroxymetaboliten, CYP-Eicosanoide, die als sekundäre Botenstoffe bei der Regulation von Gefäß-, Nieren- und Herzfunktionen fungieren. Die genauen molekularen Mechanismen dieser Metabolite sind noch weitgehend unerforscht. In der vorliegenden Arbeit wurde zunächst der ernährungsbedingte Einfluss auf das endogene CYP-Eicosanoidprofil im Menschen untersucht. Die Ergebnisse der klinischen Studie zeigten, dass n-3 PUFAs auch in vivo alternative Substrate von CYP-Enzymen darstellen und wenn verfügbar sogar effektiver zu ihren Metaboliten umgesetzt wurden als AA. Als ein wichtiger Metabolit entsteht nach EPA/DHA-Supplementation 17,18-EEQ, welcher womöglich der eigentliche Vermittler der kardioprotektiven Effekte von n-3 PUFAs ist. Unter Verwendung eines etablierten Zellmodells mit spontan schlagenden neonatalen Rattenkardiomyozyten (NRKMs) wurde der anti-arrhythmische Effekte von 17,18-EEQ genauer untersucht. Der negativ chronotrope Effekt von EPA auf NRKMs wurde tatsächlich durch 17,18-EEQ vermittelt, insbesondere dem R,S-Enantiomer. Mittels Strukturfunktionsanalyse wurden synthetische Analoga mit gleicher Wirksamkeit wie dem 7,18-EEQ gefunden, wobei strikte strukturelle Merkmale für die biologische Funktion identifiziert wurden. Die Suche nach einem molekularen Ziel für CYP-Epoxyeicosanoide führte zu einem möglichen Rezeptorkandidaten, der hinsichtlich seiner Ligandenspezifität untersucht wurde. Dieser oder zukünftige andere Rezeptorkandidaten stellen ein mögliches neues zelluläres Ziel zur Behandlung kardialer Arrhythmien dar. / The n-3 polyunsaturated fatty acids (n-3 PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), protect from cardiovascular disease, especially from fetal arrhythmia. Moreover, in vitro studies proved that recombinant cytochrome P450 (CYP) enzymes not only accept the physiologically most important n-6 PUFA arachidonic acid (AA), but also EPA and DHA as alternative substrates, thereby generating regio- and stereospecific biologically active epoxy- and hydroxymetabolites, CYP-eicosanoids. These metabolites serve as second messengers regulating vascular, renal and cardiac function. The precise underlying molecular mechanisms are only partially understood and need further investigation. The first aim of the thesis was to show that the endogenous CYP-eicosanoid profile depends on the availability of the precursor fatty acids. The results of a clinical trial with 20 volunteers, show that n-3 PUFAs serve also in vivo as alternative CYP-dependent substrates and are even preferentially metabolized compared to AA. After EPA/DHA-supplementation 17,18 EEQ was generated as a major metabolite, potentially an important mediator of cardiovascular effects originally attributed to n-3 PUFAs. To test the anti-arrhythmic effect of EPA and 17,18-EEQ, an established cell model with neonatal rat cardiomyocytes (NRKMs) was used. The negative chronotropic effect of EPA was mimicked by 17,18-EEQ, attributed only to the R,S-enantiomer. A structure activity relationship study revealed synthetic analogs, exerting the same biological effect as 17,18-EEQ. Strict structural requirements were found for agonistic function, hinting at a specific interaction with cellular targets, like GPCRs. The search of a molecular target of CYP-eicosanoids led to a putative receptor, which was tested for ligand binding specificity. If the preliminary results on the ligand binding are confirmed in future experiments this receptor might be a novel target for the treatment of cardiac arrhythmia.

A esteatose hepática não alcóolica está relacionada às causas crescentes de morbimortalidade de doenças hepáticas. Sua incidência está relacionada à obesidade e comorbidades vinculadas a esta, na qual tem despertado grande interesse na pesquisa. A modulação quantitativa da dieta pode promover ou retardar a patologia. Desta forma, terapias voltadas para retardar ou diminuir a esteatose hepática não alcóolica poderiam atenuar o dano hepático, melhorar a função hepática e reduzir sua progressão. Os objetivos do presente estudo foram: avaliar o consumo de óleos vegetais ricos em MUFAs e PUFAs usados comercialmente na prevenção ou redução da esteatose hepática analisando parâmetros do metabolismo lipídico hepático e sérico, estresse oxidativo e retardando a progressão de NAFLD. Material e Métodos: os animais foram divididos nos seguintes grupos: Controle (n=10) + HLF * (n=10); Grupo HLF * AZ (n=10); Grupo HLF* CN (n=10); Grupo HLF* S (n=10). Após 16 semanas de dieta e tratamento com os respectivos óleos, os animais foram anestesiados e o sangue retirado por punção cardíaca e os tecidos para as análises posteriores. Resultados: A oferta de uma dieta rica em gordura saturada (banha) + frutose ocasionou um aumento do peso no grupo HLF enquanto a administração dos respectivos óleos vegetais foi capaz de retardar o ganho de peso. O peso hepático e da soma dos tecidos adiposos epididimal e retroperitonial foi maior no HLF enquanto houve redução significativa no peso hepático HLF/S. O tecido retroperitonial foi menor no HLF/CN. De uma maneira geral o tratamento com os respectivos óleos vegetais diminui a esteatose em todos os grupos experimentais. A oferta de azeite extra virgem não refletiu no ganho de peso, porém o grupo teve um aumento significativo de TG e VLDL séricos, com diminuição do colesterol sérico. Avaliado histologicamente diminuiu o score de esteatose quando comparado ao HLF sendo classificado como esteatose macro e microvesicular de leve a moderada. O óleo de soja apresentou uma maior quantidade de PUFAs, sendo rico em n-6, refletiu na manutenção do peso dos animais, diminuiu a esteatose, sendo classificado como esteatatose leve, quando comparado ao HLF, porém aumentou o colesterol sérico. Apresentou um aumento de MDA e diminuição de GSH hepático. O óleo de canola devido a seu teor em ácidos graxos PUFAs (n-6 e n-3) teve maior incorporação do EPA e DHA que parecem ter evidenciado positivamente. Não apresentou alteração nos parâmetros bioquímicos e apresentou menor acúmulo de gordura hepática através da análise do percentual de gordura hepática e histopatologia, sendo caracterizado como esteatose leve. Pela peroxidação lipídica apresentou um maior acúmulo de MDA, porém um aumento de GSH. Contudo, a oferta dos respectivos óleos influenciou positivamente em diferentes mecanismos fisiológicos. / The Non-alcoholic fatty liver is related to the increasing causes of morbidity and mortality of liver diases. Its incidence is related to obesity and comorbidities linked to it, in which it has awaked great interest in the research. The disease is associated to genetic predisposition, lack of physical activity and high intake of saturated fats and fructose. Quantitative modulation of the diet may promote or retard the pathology. Thus, therapies aimed at delaying or decreasing non alcoholic hepatic steatosis could alleviate liver damage, improve liver function and reduce its progression. The objectives of the present study were: to evaluate the consumption of vegetable oils rich in commercially available MUFAs and PUFAs in the prevention or reduction of hepatic steatosis by analyzing parameters of hepatic and serum lipid metabolism, oxidative stress and delaying the progression of NAFLD. Material and Methods: animals were divided into the following groups: Control (n = 10) + HLF * (n = 10); Group HLF * AZ (n = 10); Group HLF * CN (n = 10); Group HLF * S (n = 10). After 16 weeks of diet and treatment with the respective oils, the animals were anesthetized and blood was withdrawn by cardiac puncture and tissues for further analysis. Results: The supply of a diet rich in saturated fat (lard) + fructose caused an increase in weight in the HLF group while the administration of the respective vegetable oils was able to delay the weight gain. Liver weight and sum of epididymal and retroperitoneal adipose tissues were higher in HLF while there was a significant reduction in HLF / S hepatic weight. Retroperitoneal tissue was lower in HLF / CN. In general, treatment with the respective vegetable oils decreases steatosis in all experimental groups. The supply of extra virgin olive oil did not reflect weight gain, but the group had a significant increase in serum TG and VLDL, with a decrease in serum cholesterol. Histologically it reduced the steatosis score when compared to the HLF being classified as mild to moderate macro and microvesicular steatosis. Soybean oil presented a higher amount of PUFAs, being rich in n-6, reflected in the maintenance of animal weight, decreased steatosis, being classified as mild steatosis when compared to HLF, but increased serum cholesterol. He presented an increase of MDA and decrease of hepatic GSH. Canola oil due to its content of PUFAs (n-6 and n-3) had greater incorporation of EPA and DHA than appear to have been positively evidenced. There was no alteration in the biochemical parameters and presented lower accumulation of liver fat through the analysis of the percentage of liver fat and histopathology, being characterized as mild steatosis. By the lipid peroxidation presented a greater accumulation of MDA, but an increase of GSH. However, the supply of the respective oils had a positive influence on different physiological mechanisms.

L’obésité est associée à un état inflammatoire chronique de bas grade ainsi qu’à descomplications métaboliques secondaires telles que l’insulino-résistance, l’intolérance au glucose etla stéatose hépatique. La composition bactérienne intestinale semble tenir une place importantedans l’apparition de ces complications. Il a en effet été montré qu’une altération du microbiote parun régime obésogène était associée à une endotoxémie métabolique caractérisée par uneaugmentation des concentrations circulantes de lipopolysaccharides bactériens. Les AGPI enn-3 possèdent des propriétés anti-obésogènes et anti-inflammatoires qui pourraient passer par unemodulation du microbiote intestinal et une prévention de l’endotoxémie métabolique. Nous avonsmontré que des souris transgéniques fat-1, présentant des teneurs tissulaires en AGPI enn-3 élevées, soumises durant 18 semaines à un régime obésogène, étaient résistantes à l’obésité etaux troubles métaboliques associés. Ces animaux présentent un maintien de la fonction barrièreintestinale et une prévention de l’endotoxémie métabolique. De plus, une analyse du microbiotecaecal révèle une augmentation du phylum Akkermansia. Enfin, nous avons montré qu’un transfertde matériel fécal de souris fat-1 à des souris sauvages maintenues sous régime obésogène protègeces dernières du développement d’une obésité et des comorbidités associées. Ainsi, uneaugmentation de la teneur en Akkermansia au niveau intestinal par les AGPI en n-3, peutreprésenter une stratégie intéressante de prévention de l’obésité, ainsi que de l’insulino-résistance,l’intolérance au glucose et la stéatose hépatique qui lui sont associées. / Obesity is associated with chronic low-grade inflammatory state and secondary metabolicdisorders, such as insulin-resistance, glucose intolerance and hepatic steatosis. Gut microbiotaseems to play an important role in these obesity features. Moreover, microbiota dysbiosis has beenshown to be associated with increased systemic lipopolysaccharides levels, called metabolicendotoxemia. N-3 PUFAs are anti-obesity and anti-inflammatory molecules able to modulate gutmicrobiota and prevent metabolic endotoxemia. We showed that fat-1 transgenic mice,endogenously synthetizing n-3 PUFAs, resist to obesity development and comorbidities whensubmitted to diet-induced obesity for 18 weeks. These mice exhibit a maintained intestinal barrierfunction and a prevention of metabolic endotoxemia. Moreover, cecal microbiota analysis revealedan increase of Akkermansia phylum. Microbiota transplantation of fat-1 mice to wild type micewas shown to exert protective effects against diet-induced obesity and associated disorders. Thus,increasing gut microbiota Akkermansia population by appropriate n-3 PUFAs may represent apromising strategy to prevent obesity, insulin-resistance, glucose intolerance and hepatic steatosis.

A esteatose hepática não alcóolica está relacionada às causas crescentes de morbimortalidade de doenças hepáticas. Sua incidência está relacionada à obesidade e comorbidades vinculadas a esta, na qual tem despertado grande interesse na pesquisa. A modulação quantitativa da dieta pode promover ou retardar a patologia. Desta forma, terapias voltadas para retardar ou diminuir a esteatose hepática não alcóolica poderiam atenuar o dano hepático, melhorar a função hepática e reduzir sua progressão. Os objetivos do presente estudo foram: avaliar o consumo de óleos vegetais ricos em MUFAs e PUFAs usados comercialmente na prevenção ou redução da esteatose hepática analisando parâmetros do metabolismo lipídico hepático e sérico, estresse oxidativo e retardando a progressão de NAFLD. Material e Métodos: os animais foram divididos nos seguintes grupos: Controle (n=10) + HLF * (n=10); Grupo HLF * AZ (n=10); Grupo HLF* CN (n=10); Grupo HLF* S (n=10). Após 16 semanas de dieta e tratamento com os respectivos óleos, os animais foram anestesiados e o sangue retirado por punção cardíaca e os tecidos para as análises posteriores. Resultados: A oferta de uma dieta rica em gordura saturada (banha) + frutose ocasionou um aumento do peso no grupo HLF enquanto a administração dos respectivos óleos vegetais foi capaz de retardar o ganho de peso. O peso hepático e da soma dos tecidos adiposos epididimal e retroperitonial foi maior no HLF enquanto houve redução significativa no peso hepático HLF/S. O tecido retroperitonial foi menor no HLF/CN. De uma maneira geral o tratamento com os respectivos óleos vegetais diminui a esteatose em todos os grupos experimentais. A oferta de azeite extra virgem não refletiu no ganho de peso, porém o grupo teve um aumento significativo de TG e VLDL séricos, com diminuição do colesterol sérico. Avaliado histologicamente diminuiu o score de esteatose quando comparado ao HLF sendo classificado como esteatose macro e microvesicular de leve a moderada. O óleo de soja apresentou uma maior quantidade de PUFAs, sendo rico em n-6, refletiu na manutenção do peso dos animais, diminuiu a esteatose, sendo classificado como esteatatose leve, quando comparado ao HLF, porém aumentou o colesterol sérico. Apresentou um aumento de MDA e diminuição de GSH hepático. O óleo de canola devido a seu teor em ácidos graxos PUFAs (n-6 e n-3) teve maior incorporação do EPA e DHA que parecem ter evidenciado positivamente. Não apresentou alteração nos parâmetros bioquímicos e apresentou menor acúmulo de gordura hepática através da análise do percentual de gordura hepática e histopatologia, sendo caracterizado como esteatose leve. Pela peroxidação lipídica apresentou um maior acúmulo de MDA, porém um aumento de GSH. Contudo, a oferta dos respectivos óleos influenciou positivamente em diferentes mecanismos fisiológicos. / The Non-alcoholic fatty liver is related to the increasing causes of morbidity and mortality of liver diases. Its incidence is related to obesity and comorbidities linked to it, in which it has awaked great interest in the research. The disease is associated to genetic predisposition, lack of physical activity and high intake of saturated fats and fructose. Quantitative modulation of the diet may promote or retard the pathology. Thus, therapies aimed at delaying or decreasing non alcoholic hepatic steatosis could alleviate liver damage, improve liver function and reduce its progression. The objectives of the present study were: to evaluate the consumption of vegetable oils rich in commercially available MUFAs and PUFAs in the prevention or reduction of hepatic steatosis by analyzing parameters of hepatic and serum lipid metabolism, oxidative stress and delaying the progression of NAFLD. Material and Methods: animals were divided into the following groups: Control (n = 10) + HLF * (n = 10); Group HLF * AZ (n = 10); Group HLF * CN (n = 10); Group HLF * S (n = 10). After 16 weeks of diet and treatment with the respective oils, the animals were anesthetized and blood was withdrawn by cardiac puncture and tissues for further analysis. Results: The supply of a diet rich in saturated fat (lard) + fructose caused an increase in weight in the HLF group while the administration of the respective vegetable oils was able to delay the weight gain. Liver weight and sum of epididymal and retroperitoneal adipose tissues were higher in HLF while there was a significant reduction in HLF / S hepatic weight. Retroperitoneal tissue was lower in HLF / CN. In general, treatment with the respective vegetable oils decreases steatosis in all experimental groups. The supply of extra virgin olive oil did not reflect weight gain, but the group had a significant increase in serum TG and VLDL, with a decrease in serum cholesterol. Histologically it reduced the steatosis score when compared to the HLF being classified as mild to moderate macro and microvesicular steatosis. Soybean oil presented a higher amount of PUFAs, being rich in n-6, reflected in the maintenance of animal weight, decreased steatosis, being classified as mild steatosis when compared to HLF, but increased serum cholesterol. He presented an increase of MDA and decrease of hepatic GSH. Canola oil due to its content of PUFAs (n-6 and n-3) had greater incorporation of EPA and DHA than appear to have been positively evidenced. There was no alteration in the biochemical parameters and presented lower accumulation of liver fat through the analysis of the percentage of liver fat and histopathology, being characterized as mild steatosis. By the lipid peroxidation presented a greater accumulation of MDA, but an increase of GSH. However, the supply of the respective oils had a positive influence on different physiological mechanisms.